CYCLOSPORINE A IN RHEUMATOID ARTHRITIS: CURRENT DATA
Despite the advent of the new class of medications, such as gene engineering biologicals, the use of traditional essential anti-inflammatory drugs (EAID) remains the most important method of pathogenetic therapy for rheumatoid arthritis (RA). Apart from methotrexate (MT) that is the gold standard of...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2009-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/241 |
| _version_ | 1797876877969326080 |
|---|---|
| author | Elena Lvovna Luchikhina |
| author_facet | Elena Lvovna Luchikhina |
| author_sort | Elena Lvovna Luchikhina |
| collection | DOAJ |
| description | Despite the advent of the new class of medications, such as gene engineering biologicals, the use of traditional essential anti-inflammatory drugs (EAID) remains the most important method of pathogenetic therapy for rheumatoid arthritis (RA). Apart from methotrexate (MT) that is the gold standard of treatment for RA, there are a number of other effective EAIDs, including cyclosporine A (CsA, Sandimmun). The review deals with the practical aspects of using CsA in RA. Particular emphasis is laid on the capacities of combined basic therapy with CsA and MT in early RA and on the use of CsA in patients with concomitant chronic viral diseases (including viral hepatitis C). |
| first_indexed | 2024-04-10T02:08:25Z |
| format | Article |
| id | doaj.art-1c746171ec6d43bebeb923d56db68208 |
| institution | Directory Open Access Journal |
| issn | 1996-7012 2310-158X |
| language | Russian |
| last_indexed | 2024-04-10T02:08:25Z |
| publishDate | 2009-09-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj.art-1c746171ec6d43bebeb923d56db682082023-03-13T08:39:20ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2009-09-0133394410.14412/1996-7012-2009-5561546CYCLOSPORINE A IN RHEUMATOID ARTHRITIS: CURRENT DATAElena Lvovna LuchikhinaDespite the advent of the new class of medications, such as gene engineering biologicals, the use of traditional essential anti-inflammatory drugs (EAID) remains the most important method of pathogenetic therapy for rheumatoid arthritis (RA). Apart from methotrexate (MT) that is the gold standard of treatment for RA, there are a number of other effective EAIDs, including cyclosporine A (CsA, Sandimmun). The review deals with the practical aspects of using CsA in RA. Particular emphasis is laid on the capacities of combined basic therapy with CsA and MT in early RA and on the use of CsA in patients with concomitant chronic viral diseases (including viral hepatitis C).https://mrj.ima-press.net/mrj/article/view/241ревматоидный артритранний ревматоидный артритбазисная терапияциклоспорин а |
| spellingShingle | Elena Lvovna Luchikhina CYCLOSPORINE A IN RHEUMATOID ARTHRITIS: CURRENT DATA Современная ревматология ревматоидный артрит ранний ревматоидный артрит базисная терапия циклоспорин а |
| title | CYCLOSPORINE A IN RHEUMATOID ARTHRITIS: CURRENT DATA |
| title_full | CYCLOSPORINE A IN RHEUMATOID ARTHRITIS: CURRENT DATA |
| title_fullStr | CYCLOSPORINE A IN RHEUMATOID ARTHRITIS: CURRENT DATA |
| title_full_unstemmed | CYCLOSPORINE A IN RHEUMATOID ARTHRITIS: CURRENT DATA |
| title_short | CYCLOSPORINE A IN RHEUMATOID ARTHRITIS: CURRENT DATA |
| title_sort | cyclosporine a in rheumatoid arthritis current data |
| topic | ревматоидный артрит ранний ревматоидный артрит базисная терапия циклоспорин а |
| url | https://mrj.ima-press.net/mrj/article/view/241 |
| work_keys_str_mv | AT elenalvovnaluchikhina cyclosporineainrheumatoidarthritiscurrentdata |